RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析

◆英語タイトル:RegeneRx Biopharmaceuticals Inc (RGRX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81612FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its business development services include clinical development and commercialization interests in desired pharmaceutical therapeutic fields for suitable infrastructure, expertise and a long-term initiative in disease areas. RegeneRx’s research areas include neurologic and stroke; cytoskeletal research; renal disease, renal organogenesis and fibrosis; dermal scarring, stem cell, cardiovascular reperfusion injury, ophthalmic mechanisms of repair, cosmeceuticals, burns and pulmonary arterial hypertension. The company conducts research and development on novel pharmaceuticals, which protect and repair tissue and organ damage. It collaborates with universities, hospitals, and medical research institutions worldwide. RegeneRx is headquartered in Rockville, Maryland, the US.

RegeneRx Biopharmaceuticals Inc Key Recent Developments

Mar 18,2021: RegeneRx Reports Topline Results of ARISE-3 Dry Eye Trial
Feb 24,2021: RegeneRx JV Locks Clinical Trial Database for Phase 3 Dry Eye Trial
Sep 08,2020: New research paper suggests RegeneRx’s thymosin beta 4 may be useful in treating COVID-19

This comprehensive SWOT profile of RegeneRx Biopharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of RegeneRx Biopharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

RegeneRx Biopharmaceuticals Inc – Key Information
RegeneRx Biopharmaceuticals Inc – Overview
RegeneRx Biopharmaceuticals Inc – Key Employees
RegeneRx Biopharmaceuticals Inc – Key Employee Biographies
RegeneRx Biopharmaceuticals Inc – Key Operational Heads
RegeneRx Biopharmaceuticals Inc – Major Products and Services
RegeneRx Biopharmaceuticals Inc – History
RegeneRx Biopharmaceuticals Inc – Company Statement
RegeneRx Biopharmaceuticals Inc – Locations And Subsidiaries
RegeneRx Biopharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

RegeneRx Biopharmaceuticals Inc – Business Description
RegeneRx Biopharmaceuticals Inc – Corporate Strategy
RegeneRx Biopharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
RegeneRx Biopharmaceuticals Inc – Strengths
RegeneRx Biopharmaceuticals Inc – Weaknesses
RegeneRx Biopharmaceuticals Inc – Opportunities
RegeneRx Biopharmaceuticals Inc – Threats
RegeneRx Biopharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

RegeneRx Biopharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

RegeneRx Biopharmaceuticals Inc, Key Information
RegeneRx Biopharmaceuticals Inc, Key Ratios
RegeneRx Biopharmaceuticals Inc, Share Data
RegeneRx Biopharmaceuticals Inc, Major Products and Services
RegeneRx Biopharmaceuticals Inc, History
RegeneRx Biopharmaceuticals Inc, Key Employees
RegeneRx Biopharmaceuticals Inc, Key Employee Biographies
RegeneRx Biopharmaceuticals Inc, Key Operational Heads
RegeneRx Biopharmaceuticals Inc, Other Locations
RegeneRx Biopharmaceuticals Inc, Subsidiaries
RegeneRx Biopharmaceuticals Inc, Key Competitors
RegeneRx Biopharmaceuticals Inc, SWOT Analysis
RegeneRx Biopharmaceuticals Inc, Ratios based on current share price
RegeneRx Biopharmaceuticals Inc, Annual Ratios
RegeneRx Biopharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Osaka Gas Co Ltd (9532):電力:M&Aディール及び事業提携情報
    Summary Osaka Gas Co Ltd (OGCL) supplies natural gas to its customers in Kansai region, besides offering LPG, electricity and other energy-related products and services through affiliated enterprises. Its operations consist of domestic energy, environmental and non-energy, and international energy b …
  • Allianz Global Corporate & Specialty Singapore:企業の戦略・SWOT・財務分析
    Allianz Global Corporate & Specialty Singapore - Strategy, SWOT and Corporate Finance Report Summary Allianz Global Corporate & Specialty Singapore - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Boryung Medience Corp:企業の戦略・SWOT・財務分析
    Boryung Medience Corp - Strategy, SWOT and Corporate Finance Report Summary Boryung Medience Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ProMIS Neurosciences Inc (PMN)-医療機器分野:企業M&A・提携分析
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd. is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps …
  • Visterra Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Visterra Inc (Visterra), formerly Parasol Therapeutics Inc is a clinical-stage biopharmaceutical company that develops antibody therapies for the treatment of infectious diseases. The company develops precision antibody-based biological medicines for infectious and non-infectious diseases. I …
  • Endeavour Mining Corporation:企業の戦略・SWOT・財務情報
    Endeavour Mining Corporation - Strategy, SWOT and Corporate Finance Report Summary Endeavour Mining Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • China National Petroleum Corporation (CNPC):戦略・SWOT・企業財務分析
    China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report Summary China National Petroleum Corporation (CNPC) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • GL Pharm Tech Corp (204840):製薬・医療:M&Aディール及び事業提携情報
    Summary GL Pharm Tech Corp (GL Pharm) is a pharmaceutical company. The company offers drug formulations and delivery technologies for generic marketed drug. It provides incrementally modified drugs, generic drugs, and G-SOREN Tab. GL Pharm provides generic drugs such as olmesartan, atorvastatin, ler …
  • Terna SpA (TRN):電力:M&Aディール及び事業提携情報
    Summary Terna SpA (Terna) is an electricity transmission system operator (TSO). It operates high-voltage grid and carries out transmission and dispatching of electricity, maintains transmission infrastructure, plans and constructs the grid, and undertakes grid development projects. It offers special …
  • Fujikura Ltd.:企業の戦略・SWOT・財務情報
    Fujikura Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fujikura Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • RuralMetro Corp:企業の戦略的SWOT分析
    RuralMetro Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Nationwide Financial Services, Inc.:企業の戦略的SWOT分析
    Nationwide Financial Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Public Joint-Stock Company Commercial Bank Privatbank
    Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report Summary Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Kia Motors Corporation:企業の戦略・SWOT・財務情報
    Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report Summary Kia Motors Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • UBS Wealth Management:企業の戦略・SWOT・財務情報
    UBS Wealth Management - Strategy, SWOT and Corporate Finance Report Summary UBS Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Animalcare Group Plc (ANCR):企業の財務・戦略的SWOT分析
    Summary Animalcare Group Plc (Animalcare) is a animal healthcare service provider that develops and supplies veterinary medicines and services. The company offers products such as licensed veterinary medicines, companion animal identification and animal welfare products. It offers its product to dog …
  • SPI Energy Co Ltd (SPI)-エネルギー分野:企業M&A・提携分析
    Summary SPI Energy Co Ltd (SPI Energy), formerly Solar Power Inc, is a renewable energy company that offers photovoltaic solutions. The company operates in development, financing, installation, operation and sale of utility-scale and residential solar power projects in China. It also operates online …
  • Talktalk Telecom Group PLC (TALK):企業の財務・戦略的SWOT分析
    Talktalk Telecom Group PLC (TALK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Mahindra & Mahindra Limited:企業の戦略・SWOT・財務情報
    Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report Summary Mahindra & Mahindra Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Smerud Medical Research International AS:製薬・医療:M&Aディール及び事業提携情報
    Summary Smerud Medical Research International AS (Smerud Medical) is a contract research organization that offers drug development services. The company conducts clinical trials to the pharmaceutical and biotechnology companies for improving new medical compounds. It provides services such as clinic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆